Gary Owens, MD, president of Gary Owens Associates, addresses how payers can improve outcomes for persons who have pulmonary arterial hypertension (PAH).
Gary Owens, MD, president of Gary Owens Associates, talks next steps payers can take to improve outcomes among persons living with pulmonary arterial hypertension (PAH), including stepping up education effort and improving medication access.
Transcript
What can payers do to make progress against PAH?
This is a disease that is often misunderstood, underrecognized, and underdiagnosed. Hence, that 2- to 3-year journey from symptom onset. So I think payers can hopefully play a role here, too, by helping educate the community. Now, the problem is, trying to get this message across to primary care physicians who are very, very busy with many other things, including the COVID-19 pandemic.
It’s easily possible for a disease that affects 5 to 10 per 1 million to get lost in the shuffle. But I think what it really does say, when these patients are identified by payers, getting case managers involved, and getting those case managers to coordinate that team approach I talked about, as well as making sure that patients have access to the proper pharmaceutical care, is what payers could and should be doing. Not only now but going forward.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More